155 related articles for article (PubMed ID: 33581976)
1. Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.
Lin AJ; Dehdashti F; Massad LS; Thaker PH; Powell MA; Mutch DG; Schwarz JK; Markovina S; Siegel BA; Grigsby PW
Clin Oncol (R Coll Radiol); 2021 May; 33(5):300-306. PubMed ID: 33581976
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
[TBL] [Abstract][Full Text] [Related]
3. [Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET].
Paumier A; Blanchard P; Mazeron R; Dumas I; Morice P; Lhomme C; Leboulleux S; Haie-Meder C
Cancer Radiother; 2012 May; 16(3):183-9. PubMed ID: 22387194
[TBL] [Abstract][Full Text] [Related]
4. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Chung YL; Horng CF; Lee PI; Chen FL
BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
[TBL] [Abstract][Full Text] [Related]
5. Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.
Takiar V; Fontanilla HP; Eifel PJ; Jhingran A; Kelly P; Iyer RB; Levenback CF; Zhang Y; Dong L; Klopp A
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1045-50. PubMed ID: 23332221
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer.
Im HJ; Yoon HJ; Lee ES; Kim TS; Kim JY; Chung JK; Kim SK; Park SY
Nucl Med Commun; 2014 Mar; 35(3):268-75. PubMed ID: 24253568
[TBL] [Abstract][Full Text] [Related]
7. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
[TBL] [Abstract][Full Text] [Related]
8. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS
Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420
[TBL] [Abstract][Full Text] [Related]
10. Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?
Akkas BE; Demirel BB; Dizman A; Vural GU
Ann Nucl Med; 2013 Oct; 27(8):756-63. PubMed ID: 23793926
[TBL] [Abstract][Full Text] [Related]
11. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
12. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
Cancer; 2010 Mar; 116(6):1469-75. PubMed ID: 20108309
[TBL] [Abstract][Full Text] [Related]
13. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy.
Onal C; Reyhan M; Guler OC; Yapar AF
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1336-42. PubMed ID: 24562649
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
[TBL] [Abstract][Full Text] [Related]
16. Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis.
Carpenter DJ; Jacobs CD; Wong TZ; Craciunescu O; Chino JP
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):356-366. PubMed ID: 31254659
[TBL] [Abstract][Full Text] [Related]
17. False negative rate at
Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy.
Onal C; Guler OC; Reyhan M; Yapar AF
J Gynecol Oncol; 2021 Sep; 32(5):e74. PubMed ID: 34378362
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma - a Role in Patients with Para-aortic Lymph Node Involvement? A 10-year Institutional Experience.
Green HM; Counsell N; Ward A; McCormack M
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):e281-e290. PubMed ID: 35000828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]